KBC Group NV Lowers Position in Henry Schein, Inc. (NASDAQ:HSIC)

KBC Group NV decreased its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 34.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 148,135 shares of the company's stock after selling 77,236 shares during the quarter. KBC Group NV owned about 0.12% of Henry Schein worth $10,251,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Olstein Capital Management L.P. increased its holdings in Henry Schein by 17.2% in the 4th quarter. Olstein Capital Management L.P. now owns 109,000 shares of the company's stock valued at $7,543,000 after purchasing an additional 16,000 shares during the last quarter. Fifth Third Bancorp grew its stake in shares of Henry Schein by 11.0% in the fourth quarter. Fifth Third Bancorp now owns 3,366 shares of the company's stock valued at $233,000 after buying an additional 333 shares in the last quarter. Merit Financial Group LLC grew its stake in shares of Henry Schein by 15.8% in the fourth quarter. Merit Financial Group LLC now owns 23,137 shares of the company's stock valued at $1,601,000 after buying an additional 3,156 shares in the last quarter. Sendero Wealth Management LLC raised its holdings in shares of Henry Schein by 7.9% in the 4th quarter. Sendero Wealth Management LLC now owns 12,261 shares of the company's stock valued at $848,000 after buying an additional 898 shares during the period. Finally, Signal Advisors Wealth LLC lifted its stake in Henry Schein by 15.5% during the 4th quarter. Signal Advisors Wealth LLC now owns 5,382 shares of the company's stock worth $372,000 after acquiring an additional 723 shares in the last quarter. Hedge funds and other institutional investors own 96.62% of the company's stock.

Henry Schein Stock Up 0.2 %

HSIC traded up $0.14 on Thursday, reaching $80.01. The company's stock had a trading volume of 877,949 shares, compared to its average volume of 1,304,644. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. Henry Schein, Inc. has a fifty-two week low of $63.67 and a fifty-two week high of $82.63. The stock has a 50 day moving average of $73.19 and a two-hundred day moving average of $71.27. The company has a market capitalization of $9.98 billion, a price-to-earnings ratio of 33.02, a P/E/G ratio of 2.04 and a beta of 0.89.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, topping the consensus estimate of $1.17 by $0.05. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The firm had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. During the same period last year, the business earned $1.32 EPS. Henry Schein's revenue for the quarter was up .4% compared to the same quarter last year. As a group, analysts forecast that Henry Schein, Inc. will post 4.78 EPS for the current fiscal year.

Analyst Ratings Changes

HSIC has been the topic of a number of recent research reports. Mizuho began coverage on shares of Henry Schein in a research note on Wednesday, December 4th. They set a "neutral" rating and a $75.00 price target on the stock. StockNews.com raised shares of Henry Schein from a "sell" rating to a "hold" rating in a research note on Thursday, November 7th. Bank of America raised shares of Henry Schein from an "underperform" rating to a "buy" rating and raised their price target for the company from $69.00 to $84.00 in a research report on Monday, January 6th. Evercore ISI upped their price objective on Henry Schein from $70.00 to $74.00 and gave the stock an "in-line" rating in a research report on Tuesday, October 8th. Finally, Jefferies Financial Group lifted their target price on Henry Schein from $77.00 to $80.00 and gave the company a "hold" rating in a report on Thursday, January 23rd. Seven equities research analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $80.10.

Insider Activity at Henry Schein

In other news, COO Michael S. Ettinger sold 12,240 shares of the company's stock in a transaction dated Monday, November 18th. The shares were sold at an average price of $75.00, for a total value of $918,000.00. Following the completion of the sale, the chief operating officer now directly owns 87,706 shares of the company's stock, valued at approximately $6,577,950. This represents a 12.25 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 1.14% of the company's stock.

Henry Schein Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.